What Makes Raptim Special?
Late phase trials
0
+
18+ Therapy areas
BABE studies
0
+
600+ methods
team
0
+
14+ Global locations
Raptim Research
Private Limited
Formerly known as Raptim Research Limited, is a global independent and internationally accredited Contract Research Organization (CRO), established in 2005 with state-of-the-art clinical research facilities in Mumbai and Gandhinagar (India).
Vision
To support our clients achieving the fastest path to regulatory, scientific and clinical approvals of drugs, biologics, and medical devices, supported with our high end expertise and decades of experience accumulated over time and delivering precision, while maintaining the highest levels of ethical and scientific standards
Mission
Our goal is to become one of the global leaders in Clinical Research Services, to offer complete width and depth of service expertise to our customers with unmatched service quality, to remain committed to our Human Care Management and to continue to garner more international regulatory approvals as we strive for a greater global presence.
Leadership
Dr. Rajen Shah
Founder and Director
Dr. Rajen Shah
Founder and Director
Dr. Rajen Shah is the founder and Director of Raptim. He is a Ph.D. from the University of Maryland (US), and a Bachelor in Pharmacy.
Dr. Rajen Shah has worked in the research group of Global Pharmaceutical companies like Novartis in the US and Basel for more than 14 years and has more than 22 years of Regulatory and CRO experience in India.
Mr. Viraj Shah
Founder and Director
Mr. Viraj Shah
Founder and Director
Mr. Viraj Shah is the co-founder and Director of Raptim. He is a post-graduate in
Business Administration from the University of Richmond, US.
Mr. Shah has 25+ years of experience in Global Equity Finance and Management in USA & UK, and 15+ years of experience in the CRO industry.
Meet the Team
A dedicated group of experts driving excellence in clinical research and innovation.
Dr. Milind Bagul
VP of Bioanalytical & Business Operations
Dr. Milind Bagul
Head Analytical Services
Dr. Bagul is M.Pharm, and Ph.D in Pharmaceutical Sciences. He has over 19 years of experience in managing Biopharmaceutical Studies and is associated with Raptim for more than 17 years. He is the pillar in developing the In Vitro service portfolio of Raptim. He is overall responsible for the entire analytical work carried out in the lab, In-vitro study management, Project allocation and management, Client co-ordination Laboratory supervision, and Implementation of Good laboratory practices within the department. During his tenure, he handled regulatory queries and support in inspection from the US, Europe, India, and WHO for analytical projects.
Dr. Chirag Shah
Head-Clinical Operations
Dr. Chirag Shah
Head Clinical Operations
Dr. Chirag is M.Pharm,Ph.D (Clinical Pharmacology) with PGDPM. He has 25+ years of experience in Clinical Development (Phase I-IV), Global Project Management, Regulatory, Setting up new department, M & A, and Business Strategy in Pharma, Biotech and CRO Industry. He is an associate member of American College of Clinical Pharmacology (ACCP), American Society of Clinical Oncology (ASCO), Life member of Indian Pharmacological Society (IPS), Indian Society of Clinical Research (ISCR) and Drug Information Association (DIA).
Mrs. Usha Ramakrishnan
Head-Quality Assurance
Mrs. Usha Ramakrishnan
Head, Quality Assurance
Mrs. Ramakrishnan is Bachelor of Pharmacy and Diploma in Industrial and Analytical Chemistry. She has extensive experience of about 33 years in Quality Assurance with various pharmaceutical companies and Contract Research Organizations (CROs). During her tenure, she has conducted many audit programs for the execution of a good Quality Management System in the organization. She facilitated various regulatory inspections and their queries like USFDA, MHRA, WHO, Brazil, MCC, BfArM (Germany) and HPRA (Ireland), NABL (ISO 15189-2012), CAP and DCGI
Mr. Kashinath Balapalli
AVP, Client Solutions & BD
Mr. Kashinath Balapalli
AVP, Client Solutions & BD
Kashinath is Graduate in Pharmaceuticals and Masters in Software Engineering. Has 22+ years of rich CRO leadership experience in client relations, innovative solutions & strategic consultation across Operations, OPEX, BD, Sales & Marketing. During his tenure, he has supported E2E Clinical research portfolio covering Clinical Trials, DM & Stats, Medical Coding, Global Regulatory Affairs, Medical Writing and Pharmacovigilance services for numerous global top Biopharma, Medical Devices and Cosmetics companies, through consultation, services and Technology upgrades and implementations. He has deep and wide experience at leadership & governance level, across Operations, OPEX, Optimization and Automation experience, including Business Development, Sales and Presales.
Raptim Research at Industry Events
Join us at leading industry conferences to explore the future of clinical research.
BIO International Convention 2024
Attended by Dr. Chirag Shah
CPHI Worldwide
2024
Attended by Mr. Kashinath and Ms. Priyal
Malaysian Bioequivalence Workshop 2024
Keynote address by Dr. Milind Bagul
RWE2025 Event Highlights: Shaping the Future of RWE & PMS Studies
A glimpse into ground breaking discussions, expert insights, and innovative solutions like Oopus & Oomnia, transforming Real-World Evidence and Post-Marketing Surveillance studies into scalable, simplified, smart, and economical processes. Watch the event highlights.
https://www.youtube.com/watch?v=SAKNM7SO4A8